Uriel Kim1,2, Siran Koroukian2,3,4, Abby Statler2,5, Johnie Rose1,2,4. 1. Center for Community Health Integration, Case Western Reserve University School of Medicine, Cleveland, Ohio. 2. Case Comprehensive Cancer Center, Cleveland, Ohio. 3. Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio. 4. Population Cancer Analytics Shared Resource, Case Comprehensive Cancer Center, Cleveland, Ohio. 5. Taussig Cancer Institute, The Cleveland Clinic Foundation, Cleveland, Ohio.
Abstract
BACKGROUND: Several states have opted to expand Medicaid under the Patient Protection and Affordable Care Act (ACA), which offers insurance coverage to low-income individuals up to 138% of the federal poverty level. This expansion of Medicaid to a medically vulnerable population potentially can reduce cancer outcome disparities, especially among patients with screening-amenable cancers. The objective of the current study was to estimate the effect of Medicaid expansion on the percentage of adults from low-income communities with screening-amenable cancers who present with metastatic disease. METHODS: Using state cancer registry data linked with block group-level income data, a total of 12,760 individuals aged 30 to 64 years who were diagnosed with incident invasive breast (female), cervical, colorectal, or lung cancer from 2011 through 2016 and who were uninsured or had Medicaid insurance at the time of diagnosis were identified. This sample was probability weighted based on income to reflect potential Medicaid eligibility under the ACA's Medicaid expansion. A multivariable logistic model then was fitted to examine the independent association between the exposure (pre-expansion [years 2011-2013] vs postexpansion [years 2014-2016]) and the outcome (metastatic vs nonmetastatic disease at the time of diagnosis). RESULTS: After adjusting for potential confounders, individuals who were diagnosed postexpansion were found to have 15% lower odds of having metastatic disease compared with those who were diagnosed pre-expansion (adjusted odds ratio, 0.85; 95% confidence interval, 0.77-0.93). As a control, a separate analysis that focused on individuals with private insurance who resided in high-income communities found nonsignificant postexpansion (vs pre-expansion) changes in the outcome (adjusted odds ratio, 1.02; 95% confidence interval, 0.96-1.09). CONCLUSIONS: Medicaid expansion is associated with a narrowing of a critical cancer outcome disparity in adults from low-income communities.
BACKGROUND: Several states have opted to expand Medicaid under the Patient Protection and Affordable Care Act (ACA), which offers insurance coverage to low-income individuals up to 138% of the federal poverty level. This expansion of Medicaid to a medically vulnerable population potentially can reduce cancer outcome disparities, especially among patients with screening-amenable cancers. The objective of the current study was to estimate the effect of Medicaid expansion on the percentage of adults from low-income communities with screening-amenable cancers who present with metastatic disease. METHODS: Using state cancer registry data linked with block group-level income data, a total of 12,760 individuals aged 30 to 64 years who were diagnosed with incident invasive breast (female), cervical, colorectal, or lung cancer from 2011 through 2016 and who were uninsured or had Medicaid insurance at the time of diagnosis were identified. This sample was probability weighted based on income to reflect potential Medicaid eligibility under the ACA's Medicaid expansion. A multivariable logistic model then was fitted to examine the independent association between the exposure (pre-expansion [years 2011-2013] vs postexpansion [years 2014-2016]) and the outcome (metastatic vs nonmetastatic disease at the time of diagnosis). RESULTS: After adjusting for potential confounders, individuals who were diagnosed postexpansion were found to have 15% lower odds of having metastatic disease compared with those who were diagnosed pre-expansion (adjusted odds ratio, 0.85; 95% confidence interval, 0.77-0.93). As a control, a separate analysis that focused on individuals with private insurance who resided in high-income communities found nonsignificant postexpansion (vs pre-expansion) changes in the outcome (adjusted odds ratio, 1.02; 95% confidence interval, 0.96-1.09). CONCLUSIONS: Medicaid expansion is associated with a narrowing of a critical cancer outcome disparity in adults from low-income communities.
Keywords:
Medicaid; Patient Protection and Affordable Care Act; breast neoplasms; cancer staging; colorectal neoplasms; lung neoplasms; uterine cervical neoplasms
Authors: Stacey A Fedewa; K Robin Yabroff; Robert A Smith; Ann Goding Sauer; Xuesong Han; Ahmedin Jemal Journal: Am J Prev Med Date: 2019-05-22 Impact factor: 5.043
Authors: Kirsten Bibbins-Domingo; David C Grossman; Susan J Curry; Karina W Davidson; John W Epling; Francisco A R García; Matthew W Gillman; Diane M Harper; Alex R Kemper; Alex H Krist; Ann E Kurth; C Seth Landefeld; Carol M Mangione; Douglas K Owens; William R Phillips; Maureen G Phipps; Michael P Pignone; Albert L Siu Journal: JAMA Date: 2016-06-21 Impact factor: 56.272
Authors: Paula M Lantz; Mahasin Mujahid; Kendra Schwartz; Nancy K Janz; Angela Fagerlin; Barbara Salem; Lihua Liu; Dennis Deapen; Steven J Katz Journal: Am J Public Health Date: 2006-10-31 Impact factor: 9.308
Authors: Arica White; Trevor D Thompson; Mary C White; Susan A Sabatino; Janet de Moor; Paul V Doria-Rose; Ann M Geiger; Lisa C Richardson Journal: MMWR Morb Mortal Wkly Rep Date: 2017-03-03 Impact factor: 17.586
Authors: Johnie Rose; Weichuan Dong; Uriel Kim; Joseph Hnath; Abby Statler; Paola Saroufim; Sunah Song; Mustafa Ascha; Harry Menegay; Ye Tian; Mark Beno; Siran M Koroukian Journal: Cancer Causes Control Date: 2022-04-05 Impact factor: 2.506
Authors: Erin M Mobley; Ian Tfirn; Christina Guerrier; Michael S Gutter; Kim Vigal; Keouna Pather; Brett Baskovich; Ziad T Awad; Alexander S Parker Journal: J Am Coll Surg Date: 2022-01-01 Impact factor: 6.532
Authors: Weichuan Dong; Johnie Rose; Uriel Kim; Gregory S Cooper; Jennifer Tsui; Siran M Koroukian Journal: J Public Health Manag Pract Date: 2022-04-05
Authors: Grace Lee; Edward Christopher Dee; E John Orav; Daniel W Kim; Paul L Nguyen; Alexi A Wright; Miranda B Lam Journal: Cancer Rep (Hoboken) Date: 2021-05-02